ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994